title: Buspirone-induced changes in the serotonergic and non-serotonergic cells in the dorsal raphe nucleus of rats.
abstract: Buspirone, a 5-HT (5-hydroxytryptamine, serotonin)(1A) partial agonist, is being used as an anxiolytic drug. The mechanism of action is explained by an effect on the 5-HT system. The main source of 5-HT in the forebrain is the dorsal raphe nucleus (DRN). However, there are also other populations of non-5-HT neurons in the DRN. Here, we investigated the effect of acute and chronic buspirone treatments on the 5-HT and non-5-HT cells, the neuronal nitric oxide synthase (nNOS) and tyrosine hydroxylase (TH) cells, in the DRN. Rats received either an acute or chronic administration of buspirone or saline. Hereafter, the brains were processed for 5-HT, nNOS, and TH immunohistochemistry. We found that acute and chronic buspirone treatments significantly lowered the mean optical density of nNOS in the DRN as compared to controls. Meanwhile only the chronic buspirone treatment reduced the mean density of 5-HT and TH immunoreactivity but not the acute buspirone as compared to saline treated animals. Our findings suggest that buspirone treatment affects not only the intracellular content of 5-HT but also nNOS and TH. Therefore, the cellular effect of buspirone is more complex than thought.
authors.affiliation: Department of Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.
authors.forename: Ali
authors.initials: A
authors.lastname: Jahanshahi
authors.forename: Lee Wei
authors.initials: LW
authors.lastname: Lim
authors.forename: Harry W M
authors.initials: HW
authors.lastname: Steinbusch
authors.forename: Veerle
authors.initials: V
authors.lastname: Visser-Vandewalle
authors.forename: Yasin
authors.initials: Y
authors.lastname: Temel
mesh_terms: D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D002065:Buspirone / Q000494:pharmacology*; D054333:Drug Partial Agonism; D008297:Male; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D052248:Nitric Oxide Synthase Type I / Q000378:metabolism; D011903:Raphe Nuclei / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012701:Serotonin / Q000378:metabolism*; D058825:Serotonin 5-HT1 Receptor Agonists; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
chemical_list: D014151:Anti-Anxiety Agents; D058825:Serotonin 5-HT1 Receptor Agonists; D012701:Serotonin; D052248:Nitric Oxide Synthase Type I; D014446:Tyrosine 3-Monooxygenase; D002065:Buspirone